Tetralogy of Fallot (TOF): Congenital Heart Defect — Symptoms, Surgery, and Outcomes — Overview, Diagnosis & Treatment Options | MyMedicPlus

Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart disease, first described by Étienne-Louis Arthur Fallot in 1888. It is characterized by four anatomical defects occurring together as a consequence of a single embryological anomaly — anterior deviation of the infundibular septum: (1) ventricular septal defect (VSD) — a hole in the muscular septum separating the right and left ventricles; (2) right ventricular outflow tract obstruction (RVOTO) — obstruction to blood flow from the right ventricle to the pulmonary artery, most commonly at the subpulmonary infundibulum (infundibular stenosis), pulmonary valve (valvular stenosis), or pulmonary arteries (supravalvular stenosis); (3) overriding aorta — the aortic root is displaced rightward, straddling the VSD and receiving blood from both ventricles; and (4) right ventricular hypertrophy (RVH) — a secondary consequence of the right ventricular pressure overload. TOF affects approximately 1 in 2,000–3,000 live births. With complete surgical repair, survival to adulthood now exceeds 90%, and TOF is considered one of the most successfully treated congenital heart lesions.

TOF results from abnormal neural crest cell migration during the fourth week of embryogenesis, leading to anterior and superior malalignment of the infundibular septum. Most cases of TOF are sporadic with no identifiable single genetic cause, but genetic associations are well-established. The 22q11.2 deletion syndrome (DiGeorge syndrome / velocardiofacial syndrome) — caused by a microdeletion at chromosome 22q11.2, detected by chromosomal microarray — is found in approximately 15–20% of TOF cases, particularly those with pulmonary atresia or absent pulmonary valve. GATA4, TBX1, JAG1, NOTCH1, and NKX2-5 gene mutations and copy number variants are associated with familial TOF. Down syndrome (trisomy 21) is associated with a range of congenital heart defects but less commonly with TOF specifically. Maternal risk factors include rubella infection, diabetes mellitus, phenylketonuria, and teratogen exposure (retinoic acid, alcohol). Recurrence risk for a parent with TOF having an affected child is approximately 2–3%. Genetic counseling and 22q11.2 deletion testing are recommended for all patients.

Clinical presentation depends on the degree of right ventricular outflow tract obstruction. Mild RVOTO: the neonate may be acyanotic ('pink TOF') at rest, with only exertional cyanosis. Moderate-severe RVOTO: cyanosis (blue discoloration of lips, fingernails, and skin due to mixing of deoxygenated blood across the VSD) is present at birth or develops over the first weeks of life. Central cyanosis worsens with crying, feeding, or any exertion. 'Tet spells' (hypercyanotic episodes) are a hallmark of unrepaired TOF — sudden attacks of deep cyanosis, dyspnea, agitation, then limpness and loss of consciousness, precipitated by increased oxygen demand (crying, defecation, fever). Squatting — a characteristic posture adopted by toddlers — increases systemic vascular resistance, reducing right-to-left shunting and temporarily relieving cyanosis. Clubbing (bulbous enlargement of fingertips and toes) develops with chronic hypoxemia in older unrepaired patients. Poor weight gain and failure to thrive are common due to chronic hypoxemia and dyspnea during feeding. A harsh pansystolic murmur from the VSD and a systolic ejection murmur from the RVOTO are characteristic auscultatory findings; a single second heart sound (S2) is present due to the aorta being the dominant vessel.

TOF is increasingly diagnosed prenatally by fetal echocardiography at 18–22 weeks gestation — the four-chamber view may appear normal, but outflow tract views reveal the overriding aorta and RVOTO. Postnatal diagnosis begins with clinical assessment — the presence of cyanosis, characteristic heart murmurs, and oxygen saturation below 95% on pulse oximetry prompts urgent investigation. Chest radiograph classically shows a 'boot-shaped heart' (coeur en sabot) due to right ventricular hypertrophy with a concave main pulmonary artery segment, and reduced pulmonary vascular markings. 12-lead ECG demonstrates right axis deviation and RVH. Transthoracic echocardiography (TTE) is the definitive non-invasive diagnostic modality — it characterizes all four components of TOF, assesses the degree of RVOTO (Doppler gradient across the RVOT and pulmonary valve), VSD size and location, pulmonary artery anatomy (annulus diameter, branch pulmonary artery dimensions), coronary anatomy (anomalous left anterior descending artery crossing the RVOT in ~5% of cases), and pulmonary valve morphology. Cardiac MRI provides superior pulmonary artery anatomy assessment and right ventricular volumetric analysis — essential for pre- and post-operative evaluation. Chromosomal microarray for 22q11.2 deletion and karyotype analysis are performed in all patients. Cardiac catheterization is reserved for cases with inadequate echocardiographic windows or complex pulmonary artery anatomy.

The definitive treatment is complete surgical intracardiac repair. Optimal timing is typically elective complete repair between 3–6 months of age, before significant cyanosis, polycythemia, and myocardial hypertrophy develop. Earlier repair (neonatal or infant) is indicated for severe cyanosis, recurrent tet spells, or pulmonary atresia. Palliative shunt procedures — Blalock-Taussig-Thomas (BTT) shunt (modified systemic-to-pulmonary artery shunt) — are occasionally used in very small infants or those with severe pulmonary artery hypoplasia to promote pulmonary artery growth before definitive repair. Complete surgical repair is performed on cardiopulmonary bypass: VSD closure with a Dacron patch (directing left ventricular blood exclusively to the aorta), and RVOT reconstruction — resection of hypertrophied infundibular muscle, pulmonary valvotomy, and placement of a transannular patch or bovine pericardial patch across the RVOT if the pulmonary annulus is too small (transannular patching intentionally creates pulmonary regurgitation). Pulmonary valve-sparing repair is preferred when technically feasible to avoid long-term pulmonary regurgitation. Early surgical outcomes are excellent — hospital mortality for elective repair at experienced centers is below 1%. Long-term outcomes: pulmonary regurgitation from transannular patching is the dominant late complication, causing progressive right ventricular dilatation and dysfunction, arrhythmias, and exercise intolerance over decades. Pulmonary valve replacement (PVR) — surgical or transcatheter (percutaneous Melody or SAPIEN valve implantation) — is required in approximately 30–50% of patients within 20–25 years of complete repair when RV volumes reach established criteria (RV end-diastolic volume indexed >160 mL/m² by CMR).

The prognosis for Tetralogy of Fallot has been transformed by modern surgical repair, with hospital mortality for elective complete repair falling below 1% at experienced pediatric cardiac surgical centers — a remarkable achievement compared to the near-universal childhood mortality of unrepaired TOF in the pre-surgical era. More than 90% of patients with repaired TOF now survive to adulthood, and 30-year actuarial survival rates exceed 80%. However, repaired TOF is a lifelong condition requiring specialist surveillance at Adult Congenital Heart Disease (ACHD) centers rather than a cured disease. The dominant late complication is progressive pulmonary regurgitation from the transannular patch used in the majority of surgical repairs, which causes right ventricular dilatation and dysfunction over 20–25 years and eventually requires pulmonary valve replacement (PVR) in approximately 30–50% of patients. Transcatheter PVR using Melody or SAPIEN valves is increasingly used as a less invasive alternative to surgical PVR and is suitable for many patients with an appropriate conduit or landing zone. Ventricular arrhythmias — a significant cause of late morbidity — carry a risk of sudden cardiac death of approximately 0.1–0.2% per year, necessitating ongoing Holter ECG and exercise stress testing surveillance. Exercise capacity is mildly reduced compared to healthy controls in most repaired TOF adults, but the majority can participate in moderate aerobic activity. Women with repaired TOF generally tolerate pregnancy well with appropriate specialist obstetric and ACHD co-management. Life expectancy continues to improve and is approaching that of the general population in patients with regular surveillance and timely re-intervention.

TOF cannot be prevented in sporadic cases. Preconception optimization — folic acid supplementation, rubella vaccination, optimal diabetes control, and avoidance of teratogens in women of childbearing age — reduces overall congenital heart disease risk. Prenatal fetal echocardiography at specialized centers is recommended when maternal risk factors or family history of congenital heart disease are present. All patients with repaired TOF require lifelong specialist cardiac follow-up at Adult Congenital Heart Disease (ACHD) centers. Annual or biennial cardiac MRI (CMR) and echocardiography monitor right ventricular size and function, pulmonary regurgitation severity, pulmonary artery dimensions, and residual VSD. Holter monitoring and exercise stress testing assess for arrhythmias (ventricular arrhythmias, atrial flutter, and complete heart block are known late complications). Exercise restriction is generally not required for most adult TOF survivors; exercise capacity is assessed by formal cardiopulmonary exercise testing. Pregnancy is generally well-tolerated in stable repaired TOF but requires preconception counseling, genetic testing, and high-risk obstetric and cardiology co-management. Antibiotic prophylaxis for infective endocarditis is recommended per current guidelines for specific cardiac procedures.

Central cyanosis — blue discoloration of the lips and tongue — in a newborn or young infant requires immediate emergency evaluation; it may indicate TOF or another cyanotic congenital heart defect. A 'tet spell' (sudden severe episode of cyanosis with agitation or limpness in an infant) is a cardiac emergency — the infant should be placed in the knee-chest position (simulating squatting) and emergency medical services called immediately. Parents of infants with known unrepaired TOF should receive detailed education on recognizing and initially managing tet spells. All adult survivors of repaired TOF must be under regular ACHD specialist care — irregular follow-up leads to late recognition of pulmonary valve failure, right ventricular dysfunction, and life-threatening arrhythmias. Adults with repaired TOF experiencing new palpitations, syncope, progressive exercise intolerance, or breathlessness require urgent cardiology review — these symptoms may reflect ventricular arrhythmias or significant pulmonary regurgitation requiring intervention. Women with repaired TOF planning pregnancy must consult an ACHD specialist and maternal-fetal medicine specialist before conception.